Additionally, there is an associated risk of intracranial bleeding in patients on concomitant therapy with lepirudin and rt-PA or streptokinase. A review of its pharmocology and clinical use in the management of heparin induced thrombocytopenia. Greinacher A, Alban S. Heparinoids as alternatives for parenteral anticoagulation therapy in patients with heparin induced thrombocytopenia. Monreal M, Costa J, Salva P. Pharmacological properties of hirudin and its derivatives. Contemporary use of and future roles for heparin in antithrombotic therapy.
Ancient therapy is a source of biotech drugs.
Refludan manufacture prescribing information. Hoechst Marion Roussel. Iorio A, Agnelli G. Pharmacokinetic optimization of the treatment of deep vein thrombosis. Greinacher A, Golper H, Potzsch B. Recombinant hirudin in the treatment of patients with heparin-induced thrombocytopenia. Greinacher A, Volpel H, Potzsch B. Recombinant hirudin in the treatment of patients with heparin-associated thrombocytopenia.